Microbiotica Ltd.

🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Holding
- Established
- 2016-12-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.microbiotica.com
Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)A Phase 1b Trial to Evaluate the Safety of MB310 in Patients With Active, Mild-to-Moderate Ulcerative Colitis
Phase 1
Recruiting
- Conditions
- Ulcerative Colitis
- Interventions
- First Posted Date
- 2024-09-03
- Last Posted Date
- 2025-02-21
- Lead Sponsor
- Microbiotica Ltd
- Target Recruit Count
- 30
- Registration Number
- NCT06582264
- Locations
- 🇦🇹
Medizinische Universitaet Innsbruck, Innsbruck, Austria
🇦🇹Klinikum Klagenfurt am Woerthersee, Klagenfurt, Austria
🇦🇹Uniklinikum Salzburg, Salzburg, Austria
A Phase 1b Trial to Evaluate Safety of MB097 in Combination with Pembrolizumab in Melanoma Patients
Phase 1
Recruiting
- Conditions
- Melanoma
- Interventions
- First Posted Date
- 2024-08-06
- Last Posted Date
- 2025-02-07
- Lead Sponsor
- Microbiotica Ltd
- Target Recruit Count
- 40
- Registration Number
- NCT06540391
- Locations
- 🇫🇷
Centre Georges Francois Leclerc, Dijon, France
🇫🇷CHU de Lille - Hopital Claude Huriez, Lille, France
🇫🇷Centre Leon Berard, Lyon, France
News
No news found